{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:36:25Z","timestamp":1793136985552,"version":"4.5.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Type 2 inflammation underlies the chronicity of disease in subgroups of patients with asthma, chronic rhinosinusitis with nasal polyps (CRSwNP) and atopic dermatitis (AD), that often co-exist. Although several studies have investigated the unmet needs of asthma, AD and CRSwNP as such, little is known about the similarities and differences in experiences and perspectives of the current management of patients with comorbid Type 2 inflammatory diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To improve insight into the common and organ-specific needs of patients with Type 2 inflammation and comorbidities, allowing the formulation of recommendations to better address these needs in the future.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>This qualitative study was conducted between July 2021 and December 2021 using semi-structured face-to-face or telephone interviews with patients suffering from year-long severe chronic Type 2 inflammation and at least one co-morbid inflammatory condition. Seven participating academic centers in Europe interviewed asthma (Copenhagen and Leuven), CRSwNP (London, Amsterdam and Crete) and\/or AD (Oldenburg and Zurich) patients on patient characteristics, disease severity, shortcomings of current care pathways and suggestions for improvement of care. Transcripts were analyzed using an inductive thematic analysis approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighty-one patients with severe Type 2 inflammation and comorbidities were interviewed. Similar needs were recognized by patients with Type 2 inflammation, with both a lack of coordination in care and a lack of a real cure reported as being most frustrating. However, several needs are specific to asthma, CRSwNP and AD. Suggestions for improvement of care were generic across diseases, such as the implementation of a multidisciplinary approach, the improved facilitation of access to better treatments, the increase of general awareness on disease burden, and better educational programs for healthcare providers and patients. Of note, patients with CRSwNP also stated the need for alternatives to sinus surgery, whereas patients with asthma requested better medical care to prevent exacerbations and patients with AD would warmly welcome the reimbursement of emollients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with asthma, CRSwNP and AD have shared unmet needs that need to be addressed by physicians, the academic community and health policy makers. This survey provides unique recommendations made by patients for the implementation of better care.<\/jats:p><\/jats:sec>","DOI":"10.3389\/falgy.2022.889221","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T06:52:25Z","timestamp":1654152745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREA"],"prefix":"10.3389","volume":"3","author":[{"given":"Louise","family":"De Prins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Raap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schmid-Grendelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane H.","family":"Haase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wytske","family":"Fokkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B.","family":"Benoist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Prokopakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Doulaptsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs","family":"Teeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Cypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif H.","family":"Bjermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Diamant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Wahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenis","family":"Scadding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Walther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunni R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Van Staeyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.2147\/JIR.S311640","article-title":"Insights into the implications of coexisting type 2 inflammatory diseases","volume":"14","author":"McCormick","year":"2021","journal-title":"J Inflamm Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1111\/cea.14029","article-title":"Type 2 immunity-driven diseases: towards a multidisciplinary approach","volume":"51","author":"Hassoun","year":"2021","journal-title":"Clin Exp Allergy."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jaci.2013.08.031","article-title":"Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study","volume":"132","author":"Silverberg","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B5","unstructured":"GlobalInitiative for Asthma,. Global Strategy for Asthma Management Prevention.\n          2021"},{"key":"B6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4193\/Rhin17.255","article-title":"The Global Allergy and Asthma European Network (GALEN) rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps","volume":"57","author":"Khan","year":"2019","journal-title":"Rhinology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo- controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.anai.2018.07.042","article-title":"Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.jaci.2013.02.002","article-title":"Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis","volume":"131","author":"Tan","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/all.12983","article-title":"Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre","volume":"72","author":"Van der Veen","year":"2017","journal-title":"Allergy."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/alr.22808","article-title":"A multicenter real-life study on the multiple reasons for uncontrolled allergic rhinitis","volume":"11","author":"Van Bulck","year":"2021","journal-title":"Int Forum Allergy Rhinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1111\/all.13875","article-title":"EUFOREA consensus on biologics for CRSwNP with or without asthma","volume":"74","author":"Fokkens","year":"2019","journal-title":"Allergy."},{"key":"B13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","article-title":"Comorbidities and the impact of atopic dermatitis","volume":"123","author":"Silverberg","year":"2019","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4193\/Rhin19.468","article-title":"Direct and indirect costs of adult patients with chronic rhinosinusitis with nasal polyps","volume":"58","author":"Lourijsen","year":"2020","journal-title":"Rhinology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/14737167.2020.1819793","article-title":"Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy","volume":"20","author":"Dierick","year":"2020","journal-title":"Expert Rev Pharmacoeconomics Outcomes Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2147\/JAA.S178927","article-title":"Approaches to the assessment of severe asthma: Barriers and strategies","volume":"12","author":"Majellano","year":"2019","journal-title":"J Asthma Allergy."},{"key":"B17","doi-asserted-by":"publisher","first-page":"761388","DOI":"10.3389\/falgy.2021.761388","article-title":"Patients unmet needs in chronic rhinosinusitis with nasal polyps care: a patient advisory board statement of EUFOREA","volume":"2","author":"Claeys","year":"2021","journal-title":"Front Allergy"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022644","article-title":"Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care","volume":"9","author":"Vennik","year":"2019","journal-title":"BMJ Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jaci.2006.02.031","article-title":"Patient perspectives on the management of atopic dermatitis","volume":"118","author":"Zuberbier","year":"2006","journal-title":"J Allergy Clin Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4193\/Rhin19.012","article-title":"Patient advisory board for chronic rhinosinusitis\u2013a euforea initiative","volume":"57","author":"Pugin","year":"2019","journal-title":"Rhinology."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-017-0186-3.","article-title":"European summit on the prevention and self-management of chronic respiratory diseases: report of the European Union Parliament Summit (29 March 2017)","author":"Hellings","year":"2017","journal-title":"Clin Transl Allergy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations","volume":"89","author":"O'Brien","year":"2014","journal-title":"Acad Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/jdv.14891","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1111\/jan.13031","article-title":"Systematic methodological review: developing a framework for a qualitative semi-structured interview guide","volume":"72","author":"Kallio","year":"2016","journal-title":"J Adv Nurs."},{"key":"B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijnurstu.2011.09.012","article-title":"QUAGOL: a guide for qualitative data analysis","volume":"49","author":"Dierckx de Casterle","year":"2012","journal-title":"Int J Nurs Stud."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.3390\/jcm10173981","article-title":"Physical and mental health impacts of the COVID-19 pandemic among US adults with chronic respiratory conditions","volume":"10","author":"Wei","year":"2021","journal-title":"J Clin Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/all.13162","article-title":"Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis\u2013A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement","volume":"72","author":"Hellings","year":"2017","journal-title":"Allergy."},{"key":"B29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/bmj.316.7125.133","article-title":"Integrated care pathways","volume":"316","author":"Campbell","year":"1998","journal-title":"Br Med J."},{"key":"B30","author":"Vlastos","year":"","journal-title":"Multidisciplinary Care for Severe or Uncontrolled Chronic Upper Airway Diseases"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-019-0289-0","article-title":"Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases","volume":"9","author":"Bousquet","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4193\/Rhin21.195","article-title":"Global airways\u2013a novel standard test for asthma, allergic rhinitis, and chronic rhinosinusitis (STARR-15)","volume":"60","author":"Backer","year":"2022","journal-title":"Rhinology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jaip.2020.12.059","article-title":"Dupilumab improves asthma and sinonasal outcomes in adults with moderate to severe atopic dermatitis","volume":"9","author":"Boguniewicz","year":"2021","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd4624","article-title":"Targeting key proximal drivers of type 2 inflammation in disease","volume":"15","author":"Gandhi","year":"2016","journal-title":"Nat Rev Drug Discov."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/jdv.15972","article-title":"Position statement on atopic dermatitis in Sub-Saharan Africa: current status and roadmap","volume":"33","author":"Schmid-Grendelmeier","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1398-9995.2007.01545.x","article-title":"Sinonasal pathology in nonallergic asthma and COPD: \u201cUnited airway disease\u201d beyond the scope of allergy","volume":"63","author":"Hens","year":"2008","journal-title":"Allergy."}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2022.889221\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T12:55:32Z","timestamp":1663246532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2022.889221\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":36,"alternative-id":["10.3389\/falgy.2022.889221"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2022.889221","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"article-number":"889221"}}